跳至主要内容
临床试验/DRKS00033788
DRKS00033788招募中不适用

Biomarker Discovery in Exhaled Breath Condensate (EBC) to discriminate pts with lung cancer CS I-IV from pts with COPD or lung fibrosis and healthy controls. - Lung - EBC Biomarker Discovery

VOC-Advanced Breath Diagnostics GmbH0 个研究点目标入组 238 人开始时间: 2024年3月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
238

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 2.Cohort classification:
  • a. Cohort A: Smokers or nonsmokers with no signs or symptoms of lung cancer, COPD or lung fibrosis
  • b.Cohort B: Smokers or nonsmokers with known COPD or lung fibrosis but no symptoms or signs of lung cancer
  • c.Cohort C: Smokers or nonsmokers with yet untreated lung carcinoma CS I-IV with or without COPD or lung fibrosis
  • 3. Able to sign informed consent form.
  • 4. Able to understand study requirements and to provide EBC sample by tidal breathing into a EBC collection device

排除标准

  • 1. Suffering from major uncontrolled medical conditions that may interfere with study requirements such as fever, shortness of breath, cough/acute cold.
  • 2. Previous malignancies
  • 3. Patients with COPD GOLD IV or lung fibrosis with DLCO/TCLO < 30 %
  • 4. Exacerbation of COPD within = 4 weeks before enrollment
  • 5. Dry mouth and tongue with daily liquid intake of < 1 liter/day within last 48 hours

研究者

发起方
VOC-Advanced Breath Diagnostics GmbH

相似试验

Biomarker Discovery in Exhaled Breath Condensate... | 临床试验